Career Enhancement Program
Career Enhancement Program
批准号:
10224129
负责人:
Charles David James
金额:
$9.71万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-08-17 至 2023-07-31
关键词:
AwardBrain NeoplasmsDisciplineEnsureFacultyFosteringFutureGrantHumanIndividualLeadershipLengthMalignant neoplasm of brainMentorsMinorityMonitorProcessProgress ReportsPublicationsRequest for ApplicationsResearchResearch PersonnelScientistSourceStructureSystemTalentsTrainingWomananticancer researchbasecareercareer developmentfaculty mentorflexibilityinterestmeetingsneuro-oncologyprogramsrecruitsymposiumtranslational approach
中文摘要
点击翻译按钮获取中文摘要
英文摘要
CAREER ENHANCEMENT PROGRAM: SUMMARY
The Northwestern Brain Tumor SPORE (NBTS) Career Enhancement Program (CEP) is responsible for
recruitment and training of new and early stage investigators committed to neuro-oncology research to ensure
that there will be a continuous source of talented investigators committed to this field. The fact that the faculty
mentors come from a variety of departments and disciplines provides a source of diversity and scientific
expertise to program awardees. CEP recipients are selected after wide solicitation of the request for
applications and careful review of applicants' credentials and potential to develop an independent career in
brain tumor research. The CEP leadership, Drs. James and Lesniak, will make special efforts to emphasize
the recruitment of women and minorities to the SPORE CEP, both at the levels of award recipients and
mentors.
The CEP has flexibility in terms of offering awards and the length of the award. However, there is a consistent
and highly-structured process for solicitation and selection of CEP investigators and a detailed tracking system
for monitoring their progress. The specific aims of the CEP are:
1. To maintain an administrative structure for the Career Enhancement Program.
2. To solicit and select career enhancement investigators through a highly structured process.
3. To mentor and continuously evaluate career enhancement investigators through individual meetings with
mentors, bi-annual presentations at SPORE investigator work in progress meetings and written progress
reports.
4. To cultivate new faculty to embark on careers in neuro-oncology to ensure a future source of talented
investigators committed to brain cancer research.
!
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SLFN5: A Novel Therapeutic Target for Glioblastoma
-
批准号:10240565
-
项目类别:
-
资助金额:$34.56万
-
财政年份:2019
-
负责人:Charles David James
-
依托单位:
SLFN5: A Novel Therapeutic Target for Glioblastoma
-
批准号:10468276
-
项目类别:
-
资助金额:$34.56万
-
财政年份:2019
-
负责人:Charles David James
-
依托单位:
Career Enhancement Program
-
批准号:10478884
-
项目类别:
-
资助金额:$7.85万
-
财政年份:2018
-
负责人:Charles David James
-
依托单位:
BRAF Mutation in Malignant Astrocytoma Origin, Evolution, and Response to Therapy
-
批准号:9134221
-
项目类别:
-
资助金额:$35.65万
-
财政年份:2014
-
负责人:Charles David James
-
依托单位:
BRAF Mutation in Malignant Astrocytoma Origin, Evolution, and Response to Therapy
-
批准号:8901528
-
项目类别:
-
资助金额:$35.2万
-
财政年份:2014
-
负责人:Charles David James
-
依托单位:
PRE-CLINICAL ANIMAL CORE
-
批准号:8514330
-
项目类别:
-
资助金额:$16.49万
-
财政年份:2013
-
负责人:Charles David James
-
依托单位:
NOVEL APPROACAHES FOR IMPROVING PEDIATRIC BRAFV600E GLIOMA PATIENT OUTCOMES
-
批准号:8514312
-
项目类别:
-
资助金额:$27.15万
-
财政年份:2013
-
负责人:Charles David James
-
依托单位:
BRAF Mutation in Malignant Astrocytoma Origin, Evolution, and Response to Therapy
-
批准号:8402661
-
项目类别:
-
资助金额:$35.22万
-
财政年份:2012
-
负责人:Charles David James
-
依托单位:
Cdk4/6 Inhibitor Therapy for Glioblastoma Multiforme
-
批准号:8658297
-
项目类别:
-
资助金额:$31.2万
-
财政年份:2012
-
负责人:Charles David James
-
依托单位:
Cdk4/6 Inhibitor Therapy for Glioblastoma Multiforme
-
批准号:8840899
-
项目类别:
-
资助金额:$32.16万
-
财政年份:2012
-
负责人:Charles David James
-
依托单位:
Cdk4/6 Inhibitor Therapy for Glioblastoma Multiforme
-
批准号:8314300
-
项目类别:
-
资助金额:$33.49万
-
财政年份:2012
-
负责人:Charles David James
-
依托单位:
BRAF Mutation in Malignant Astrocytoma Origin, Evolution, and Response to Therapy
-
批准号:8529270
-
项目类别:
-
资助金额:$34.11万
-
财政年份:2012
-
负责人:Charles David James
-
依托单位:
Cdk4/6 Inhibitor Therapy for Glioblastoma Multiforme
-
批准号:8463483
-
项目类别:
-
资助金额:$30.22万
-
财政年份:2012
-
负责人:Charles David James
-
依托单位:
EGRF Targeting of Therapeutic Liposomes for Treating Gliobastoma
-
批准号:7843605
-
项目类别:
-
资助金额:$19.31万
-
财政年份:2009
-
负责人:Charles David James
-
依托单位:
Xenograft Model for Studying Amplified EGFR in GBM
-
批准号:6825627
-
项目类别:
-
资助金额:$30.12万
-
财政年份:2004
-
负责人:Charles David James
-
依托单位:
Xenograft Model for Studying Amplified EGFR in GBM
-
批准号:7228952
-
项目类别:
-
资助金额:$30.37万
-
财政年份:2004
-
负责人:Charles David James
-
依托单位:
Core--Xenograft Facility
-
批准号:6844503
-
项目类别:
-
资助金额:$16.36万
-
财政年份:2004
-
负责人:Charles David James
-
依托单位:
Xenograft Model for Studying Amplified EGFR in GBM
-
批准号:7405313
-
项目类别:
-
资助金额:$30.46万
-
财政年份:2004
-
负责人:Charles David James
-
依托单位:
Xenograft Model for Studying Amplified EGFR in GBM
-
批准号:6928574
-
项目类别:
-
资助金额:$28.93万
-
财政年份:2004
-
负责人:Charles David James
-
依托单位:
Xenograft Model for Studying Amplified EGFR in GBM
-
批准号:7276913
-
项目类别:
-
资助金额:$28.25万
-
财政年份:2004
-
负责人:Charles David James
-
依托单位:
海外基金